The NIHR Great Ormond Street Hospital Biomedical Research Centre (BRC) supports experimental medicine research for children and young people at Great Ormond Street Hospital (GOSH) and the UCL Institute of Child Health (ICH).
GOSH and the ICH were first awarded BRC status by the National Institute for Health Research (NIHR) in 2007. In 2016, the GOSH BRC secured £37 million to take it into its third term, which will run from April 2017 to March 2022.
The funding enables basic scientific discoveries made in laboratories to be translated into ‘first in man’ or ‘first in child’ clinical studies. Our research aims to accelerate discoveries into the basis of childhood rare diseases and to develop new diagnostics, imaging techniques and treatments, including cellular and gene therapies.
The BRC is ideally positioned to deliver this, as GOSH is the largest recipient of nationally commissioned NHS services in the UK.
Over this five-year funding period, we will be investing over £35 million into our research programmes. These include the Centre for Translational Genomics (GOSgene), the Gene and Cell Therapy Facility and the Translational Biomarker Discovery Unit.